Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomas
- 1 November 1991
- Vol. 68 (9) , 2037-2044
- https://doi.org/10.1002/1097-0142(19911101)68:9<2037::aid-cncr2820680932>3.0.co;2-c
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Problems of mass screening for neuroblastoma: Analysis of false-negative casesJournal of Pediatric Surgery, 1990
- Improved survival rates in children over 1 year of age with stage III or IV neuroblastoma following an intensive chemotherapeutic regimenJournal of Pediatric Surgery, 1989
- Japanese experience of screeningMedical and Pediatric Oncology, 1989
- Dopaminergic neuroblastoma as a poor prognostic subgroupJournal of Pediatric Surgery, 1988
- Chromosome findings and prognosis in 15 patients with neuroblastoma found by VMA mass screeningThe Journal of Pediatrics, 1988
- Amplification of N-myc oncogene in stage II and IVS neuroblastomas may be a prognostic indicatorJournal of Pediatric Surgery, 1987
- N-myc ONCOGENE AMPLIFICATION AND CATECHOLAMINE METABOLISM CHILDREN WITH NEUROBLASTOMAThe Lancet, 1987
- N-myc amplification causes down-modulation of MHC class I antigen expression in neuroblastomaCell, 1986
- Association of Multiple Copies of the N-mycOncogene with Rapid Progression of NeuroblastomasNew England Journal of Medicine, 1985
- The coincidence of neuroblastoma and acute cerebellar encephalopathyThe Journal of Pediatrics, 1969